Tower Research Capital (TRC)’s ClearPoint Neuro CLPT Stock Holding History
Bought
Maintained
Sold
Other funds holding CLPT
Tower Research Capital (TRC)'s CLPT Position: Q3 2026 in Review
Tower Research Capital (TRC) increased its ClearPoint Neuro (CLPT) stake by 92% in Q3 2026, buying an estimated $28.7K and bringing the position to 3,993 shares worth $48.8K. The position accounts for ﹤0.01% of the portfolio, ranked #3243.
Tower Research Capital (TRC) first reported a position in CLPT in Q2 2020 and has held it in 24 quarters since. The position peaked at $98K in Q4 2021. 114 funds tracked by Wall St. Rank hold CLPT as of Q3 2026.
- Tower Research Capital (TRC) held 3,993 shares of ClearPoint Neuro worth $48.8K as of Q3 2026.
- Tower Research Capital (TRC) bought 1,913 ClearPoint Neuro shares in Q3 2026, an estimated $28.7K.
- ClearPoint Neuro made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q3 2026, its #3243 holding.
- Tower Research Capital (TRC) first reported a position in ClearPoint Neuro in Q2 2020 and has held it in 24 quarters since.
- Tower Research Capital (TRC)'s ClearPoint Neuro position peaked at $98K in Q4 2021.
- 114 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q3 2026.
Based on Tower Research Capital (TRC)'s 13F filing for Q3 2026, filed 16 Nov 2026.